Cytomegalovirus disease in renal transplant recipients: A single-center experience

Renal Failure

Volumn 30, Issue 5, 2008, Pages 503-506

  Cavdar, Caner ^a   Celtik, Aygul ^a   Saglam, Funda ^a   Sifil, Aykut ^a   Atila, Koray ^a   Celik, Ali ^a   Tosun, Pinar ^a   Olmuscelik, Oktay ^a   Bora, Segmen ^a   Gulay, Huseyin ^a   Camsari, Taner ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Cytomegalovirus disease; Kidney transplantation

Indexed keywords

ACICLOVIR; BASILIXIMAB; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; FEMALE; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY;

ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES;

EID: 45749101253     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802064705     Document Type: Article

References (12)

1. Sageda S, Nordal KP, Hartmann A, Sund S, Scott H, Degre M, et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant. 2002;2(9):850-856.
2. Toupance O, Bouedjoro-Camus MC, Carquin J, Novella JL, Lavaud S, Wynckel A, et al. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: A cohort study with case-control analyses. Transpl Int. 2000;13(6):413-419.
3. Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy JC, Bosshard S, et al. Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation. 1993;55(4): 851-857.
4. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int. 2004;66(1):329-337.
5. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A six-year prospective study on new-onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant. 2003;18:2154-2159.
6. Pour-Reza-Gholi F, Labibi A, Farrokhi F, Nafar M, Firouzan A, Einollahi B. Signs and symptoms of cytomegalovirus disease in kidney transplant recipients. Transplant Proc. 2005;37:3056-3058.
7. Lebranchu Y, Bridoux F, Büchler M, Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Trans. 2002;2:48-56.
8. Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004 Aug 27;78(4):584-590.
9. Nemati E, Eizadi M, Moghani Lankarani M, Kardavani B, Khoddami-Vishteh H-R, Kalantar E, et al. Cytomegalovirus disease after kidney transplantation: Clues to accurate diagnosis. Transplant Proc. 2007;39:987-989.
10. Farrugia E, Schwab TR. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc. 1992;67:879.
11. Abbott KC, Hypolite IO, Viola R, Poropatich RK, Hshieh P, Cruess D, et al. Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol. 2002 Aug;12(6):402-409.
12. Durlik M, Siennicka J, Litwinska B, Majchrzak J, Trzcinska A, Samsel R, et al. Clinical manifestations and diagnosis of cytomegalovirus infection in renal allograft recipients. Transplant Proc. 2001 Feb-Mar;33(1-2):651- 653.